What is PCOS?

What is PCOS?

Despite what the name suggests, Polycystic Ovary Syndrome isn’t just about ovaries—or cysts, for that matter. In fact, many people diagnosed with PCOS don’t have any ovarian cysts at all. Confusing? You’re not alone. The name dates back to how the condition was first described, but science has come a long way since then. Today, we understand that PCOS is really a complex hormonal and metabolic condition that affects far more than reproductive health.

At its core, PCOS is about hormonal imbalance. When key hormones like insulin, androgens (like testosterone), and others are out of sync, they can create a domino effect throughout the body. This hormonal miscommunication can lead to irregular periods, acne, weight changes, hair loss or excess hair growth, difficulty with ovulation or fertility—and that’s just the shortlist. But here’s the thing: PCOS doesn’t follow a single pattern. Some women experience textbook symptoms. Others don’t fit the mold at all. That’s part of what makes PCOS so challenging—and why understanding your unique experience matters.

So, how can the PCOS Association help?

We’re here to offer more than definitions. We’re here to offer direction. Whether you’re newly diagnosed, still searching for answers, or years into your journey and feeling stuck, we’re committed to helping you make sense of PCOS—and make progress.

Here’s what you’ll find at PCOSA:

  • Reliable, science-backed information about what PCOS is (and isn’t)

  • 💬 Supportive communities of people who understand exactly what you’re going through

  • 🧬 Resources for navigating fertility, metabolic health, nutrition, and more

  • 🧠 Education for providers who want to better support their PCOS patients

  • 🙋‍♀️ Advocacy to make sure PCOS is recognized, researched, and respected

No fluff. No fad cures. Just real support, grounded in evidence and compassion.

At PCOSA, we believe every person with PCOS deserves to be informed, empowered, and heard. Wherever you are in your journey, we’re honored to walk with you.

pcos

pcos: Latest results from PubMed

Expression and significance of ependymin-related protein 1 and neuregulin 4 in the serum of patients with polycystic ovary syndrome

CONCLUSION: Serum levels of EPDR1 and NRG4 were significantly decreased in PCOS patients and showed significant correlations with key metabolic and endocrine parameters (BMI, T, HOMA-IR, LH/FSH ratio, and lipid profiles). These findings highlight their potential value as diagnostic biomarkers for PCOS, reflecting the associated metabolic disturbances.

Published on: Thu, 12 Mar 2026 06:00:00 -0400

Authors: Ren Xiaopang, Song Jie, Hao Wanjiao, Liu Man,

Efficacy and safety of Shatavari root extract in women with Polycystic Ovarian Syndrome: a randomized, double-blind, placebo-controlled trial

CONCLUSION: Shatavari root extract oral administration can be a safe and effective potential intervention for women with PCOS. The study was registered with the Clinical Trials Registry of India (CTRI) under registration number CTRI/2024/10/074660 on October 3, 2024.

Published on: Thu, 12 Mar 2026 06:00:00 -0400

Authors: Yashodhara Mhatre, Pradeep Jadhav, Adwait Malik, Mayakalyani Srivathsan, Deepak Langade,

Obesity and female reproductive health in Asian population

CONCLUSION: Obesity has significant negative effects on female reproductive health from adolescence to menopause but these issues can be reversed with effective weight management. With the increasing rate of obesity in Asia, healthcare professionals must prioritize weight management strategies to mitigate its harmful impact on women's reproductive health.

Published on: Thu, 12 Mar 2026 06:00:00 -0400

Authors: Krasean Panyakhamlerd, Areepan Sophonsritsuk, Tawiwan Pantasri, Ammarin Suwan, Nuttanun Panyawongudom, Parinya Samakkarnthai,

Tet methylcytosine dioxygenase 2(TET2)-dependent epigenetic regulation in the pathogenesis of polycystic ovary syndrome

No abstract

Published on: Wed, 11 Mar 2026 06:00:00 -0400

Authors: Kailu Liu, Yanli Hong, Qian Gao, Jingyu Huang, Li Liu, Yueyi Li, Yunteng Liang, Shuxuan Zhang, Xi He, Xiaowei Nie,

Evaluation of autonomic dysfunction with dynamic pupillometry in non-obese young women with polycystic ovary syndrome

CONCLUSION: Newly diagnosed non-obese women with polycystic ovary syndrome exhibit significant alterations in pupillary dynamics, suggesting a generalized reduction in both sympathetic and parasympathetic activity. Dynamic pupillometry may represent a practical, noninvasive tool for detecting early autonomic hypoactivity and identifying patients at risk for future metabolic or cardiovascular complications.

Published on: Wed, 11 Mar 2026 06:00:00 -0400

Authors: Kübra Gündogan, Ali Osman Gündogan, Emine Türen Demir, Naciye Tora,

Live Births Following IVF-FET in Two Adult Sisters with Nonclassic P450 Oxidoreductase Deficiency: A Case Report Identifying a Novel POR Variant

CONCLUSION: These cases represent the first report of two siblings with nonclassic PORD achieving live births through IVF-FET. Moreover, we identified a previously unreported POR variant, c.1952_1966del, p.Gly651_His655del, which expands the known mutational spectrum of PORD in the Chinese population. Our findings highlight the importance of early genetic testing in women with atypical infertility, recognition of the distinctive hormonal profile of PORD, and the value of glucocorticoid-supported...

Published on: Wed, 11 Mar 2026 06:00:00 -0400

Authors: Yichang Tian, Yan Pei, Ying Fang, Xiaokui Yang, Yu Liang,

Study of association between serum anti-Müllerian hormone, glucose intolerance, and metabolic syndrome in women with polycystic ovarian syndrome: A comparative study

CONCLUSION: Serum AMH is significantly elevated in women with PCOS and is as a potential marker for predicting metabolic risk but has no association with glucose intolerance in PCOS patients.

Published on: Wed, 11 Mar 2026 06:00:00 -0400

Authors: Namrata Anand Kondaguli, Pavanaganga A,

Ovulatory Recovery following weight loss in women with polycystic ovary syndrome and obesity: a post hoc analysis of the BAMBINI randomised controlled trial

STUDY QUESTION: What is the frequency of ovulatory recovery (OvR) after different degrees of total weight loss (TWL) in women with polycystic ovary syndrome (PCOS) and obesity, and can an excessive degree of TWL be identified that is harmful to the chance of OvR?

Published on: Wed, 11 Mar 2026 06:00:00 -0400

Authors: Suhaniya N S Samarasinghe, Ali Abbara, Patricia M Ortega, Ahmed R Ahmed, Christos Tsironis, Sanjay Purkayastha, Vinod Menon, Harpal Randeva, Alexander D Miras,

A synthetic ERFVII-dependent circuit in yeast sheds light on the regulation of early hypoxic responses of plants

Plants face hypoxic conditions either chronically, as particular tissues are characterized by fluctuating or stable low oxygen levels, or acutely, when flooded. In vascular plants, transcriptional adaptive responses to hypoxia are rapidly mounted by Ethylene Response Factors VII (ERFVIIs), regulated by Plant Cysteine Oxidases (PCOs) through the cysteine branch of the N-degron pathway (Cys-NDP) for oxygen sensing. However, this relatively simple regulatory circuit, consisting of both...

Published on: Tue, 10 Mar 2026 06:00:00 -0400

Authors: Mikel Lavilla-Puerta, Yuming He, Luca Piccinini, Lorenzo Di Paco, Antonis Papachristodoulou, Francesco Licausi, Beatrice Giuntoli,

Semaglutide alleviates ovarian ferroptosis in polycystic ovary syndrome and is associated with reduced GPX4 promoter hypermethylation

Polycystic ovary syndrome (PCOS) is associated with ovarian granulosa cell dysfunction. Ferroptosis, a regulated cell death driven by lipid peroxidation, represents a novel pathological mechanism. Hypermethylation of the glutathione peroxidase 4 (GPX4) promoter may contribute to its suppression. While glucagon-like peptide-1 receptor agonists (GLP-1 RAs) improve metabolic features of PCOS, their direct effects on ovarian ferroptosis and the underlying epigenetic mechanisms are unclear. To...

Published on: Tue, 10 Mar 2026 06:00:00 -0400

Authors: Yaling Zhang, Daojuan Wang, Xiaosa Si, Tingyu Wang, Xiaotian Chen, Dejian Chen, Yong Wang,

Ovarian Insulin Signaling Is Intact Despite Systemic Insulin Resistance in a Mouse Model of Polycystic Ovary Syndrome

Polycystic ovary syndrome (PCOS) is a systemic endocrine disorder characterized by perturbations in both androgen and insulin signaling pathways that result in anovulatory infertility and metabolic syndrome. This study aimed to elucidate insulin signaling in the PCOS ovary using a mouse model that develops both the metabolic and reproductive manifestations of PCOS due to chronic postnatal dihydrotestosterone exposure. PCOS mice developed anovulation, cystic follicles, systemic insulin resistance...

Published on: Mon, 09 Mar 2026 06:00:00 -0400

Authors: Adelaide E Weidner, Kenji Vann, Alexia I Hodowanec, Denise Ivey, Anna Roy, Zachary R Sechrist, Calvin L Cole, Olga Astapova,

Early pregnancy biomarkers of inflammation and metabolic regulation in polycystic ovary syndrome

CONCLUSIONS: MCP1 and FABP4 concentrations were elevated in early pregnancy among women with PCOS, largely reflecting maternal adiposity. These markers did not modify associations between PCOS and pregnancy outcomes. Larger longitudinal studies are needed to clarify underlying inflammatory and metabolic pathways.

Published on: Mon, 09 Mar 2026 06:00:00 -0400

Authors: Simon Alesi, Taitum Mason, Stacey J Ellery, Kate Rassie, Adriana C H Neven, Yitayeh Belsti, Eveline Jona, Sharleen O'Reilly, David Simmons, Helena Teede, Aya Mousa, IMPACT DIABETES B2B&ME, TOBOGM Study Groups,

Causal Associations Between Sleep Traits and Polycystic Ovary Syndrome: A Univariable, Bidirectional, and Multivariable Mendelian Randomization Study

CONCLUSION: Our MR analyses support a potential causal role of sleeplessness/insomnia in increasing the risk of PCOS, whereas the association with sleep apnea syndrome may be mediated by adiposity or other confounding factors. These findings highlight the importance of sleep management in strategies for the prevention of PCOS.

Published on: Mon, 09 Mar 2026 06:00:00 -0400

Authors: Xueli Chen, Jie Lin, Huanhuan Gao, Jingyi Wang, Tong Lin, Juan Yang, Fa Chen, JinBang Xu,

Protective Effect of "Ark-e-Kasni," a Unani Formulation, in Letrozole and High-Fat Diet-Induced Polycystic Ovarian Syndrome in Rats

CONCLUSION: The findings suggest that Ark-e-Kasni ameliorates PCOS through diverse molecular mechanisms. Ark-e-Kasni may modulate steroidogenic enzyme activity to reduce hyperandrogenism, enhance insulin sensitivity through the PI3K/Akt pathway, and inhibit the downstream inflammatory pathway of NF-κB.

Published on: Mon, 09 Mar 2026 06:00:00 -0400

Authors: Kamini R Shirasath, Ritu Karwasra, N Zaheer Ahmed, Pawan Kumar, Shah Alam, Sameer N Goyal, Yogeeta O Agrawal,

Performance evaluation of automated magnetic beads extraction method for the measurement of 23 plasma steroids using dual liquid chromatography-tandem mass spectrometry (LC-MS/MS) method

CONCLUSION: The automated MGE method demonstrates high efficiency and reliability for the simultaneous quantification of 23 plasma steroids, offering a promising solution for high-throughput analysis of steroid panels in clinical in the future.

Published on: Mon, 09 Mar 2026 06:00:00 -0400

Authors: Han Chen, Gang Xu, Mei-Juan Zhang, Fu-Rong Ying, Hai-Xia Huang, He-Huan Liu, Jian-Rong Yang,